Trident Texofab Limited (BOM:540726)
India · Delayed Price · Currency is INR 41.70
-2.04 (-4.66%)
At close: Jun 1, 2026
Trident Texofab Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,180 | 1,221 | 994.83 | 963.56 | 842.93 |
Other Revenue | 18.41 | - | 0 | - | - |
| 1,199 | 1,221 | 994.84 | 963.56 | 842.93 | |
Revenue Growth (YoY) | -1.80% | 22.69% | 3.25% | 14.31% | 68.83% |
Cost of Revenue | 1,052 | 1,058 | 838.32 | 803.93 | 722.59 |
Gross Profit | 146.21 | 162.33 | 156.52 | 159.64 | 120.34 |
Selling, General & Admin | 28.4 | 28.75 | 27.08 | 28.02 | 24.59 |
Other Operating Expenses | 48.34 | 78.86 | 67.89 | 49.52 | 35.77 |
Operating Expenses | 92.83 | 124.09 | 111.45 | 93.98 | 75.02 |
Operating Income | 53.37 | 38.24 | 45.07 | 65.66 | 45.31 |
Interest Expense | -29.28 | -45.26 | -40.22 | -55.63 | -39.97 |
Interest & Investment Income | - | 1.85 | 1.37 | 1.15 | 0.61 |
Currency Exchange Gain (Loss) | - | - | - | - | 0.16 |
Other Non Operating Income (Expenses) | -0 | 1.08 | 1.35 | 1.57 | 3.69 |
EBT Excluding Unusual Items | 24.1 | -4.09 | 7.56 | 12.75 | 9.79 |
Gain (Loss) on Sale of Investments | - | 29.84 | 1.02 | 15.81 | 2.52 |
Other Unusual Items | -11.27 | - | 3.11 | -1.3 | 0.43 |
Pretax Income | 12.83 | 25.76 | 11.69 | 27.26 | 12.73 |
Income Tax Expense | 5.78 | 0.66 | 0.89 | 5.08 | 2.91 |
Net Income | 7.05 | 25.1 | 10.8 | 22.18 | 9.83 |
Net Income to Common | 7.05 | 25.1 | 10.8 | 22.18 | 9.83 |
Net Income Growth | -71.93% | 132.46% | -51.32% | 125.74% | 178.31% |
Shares Outstanding (Basic) | 13 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 13 | 12 | 10 | 10 | 10 |
Shares Change (YoY) | 11.55% | 16.16% | -0.00% | 0.00% | 0.79% |
EPS (Basic) | 0.54 | 2.44 | 1.07 | 2.20 | 0.98 |
EPS (Diluted) | 0.54 | 2.09 | 1.07 | 2.20 | 0.98 |
EPS Growth | -74.16% | 95.33% | -51.36% | 125.44% | 178.82% |
Free Cash Flow | -101.52 | -137.22 | 26.56 | 56.36 | -27.64 |
Free Cash Flow Per Share | -7.78 | -11.73 | 2.64 | 5.60 | -2.75 |
Gross Margin | 12.20% | 13.30% | 15.73% | 16.57% | 14.28% |
Operating Margin | 4.45% | 3.13% | 4.53% | 6.81% | 5.38% |
Profit Margin | 0.59% | 2.06% | 1.08% | 2.30% | 1.17% |
Free Cash Flow Margin | -8.47% | -11.24% | 2.67% | 5.85% | -3.28% |
EBITDA | 69.47 | 53.4 | 60.24 | 80.81 | 58.21 |
EBITDA Margin | 5.80% | 4.38% | 6.05% | 8.39% | 6.91% |
D&A For EBITDA | 16.1 | 15.16 | 15.17 | 15.15 | 12.9 |
EBIT | 53.37 | 38.24 | 45.07 | 65.66 | 45.31 |
EBIT Margin | 4.45% | 3.13% | 4.53% | 6.81% | 5.38% |
Effective Tax Rate | 45.06% | 2.55% | 7.61% | 18.62% | 22.83% |
Revenue as Reported | 1,199 | 1,254 | 998.72 | 982.6 | 850.34 |
Advertising Expenses | - | 0.1 | 0.13 | 0.33 | 0.15 |